IONIS PHARMACEUTICALS INC

IONSSEC EDGAR

Pharmaceutical Preparations(CA)CIK: 874015

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$787.6M	$587.4M	$810.5M	$729.3M	$1.1B
Cost of Goods and Services Sold	$9.1M	$14.1M	$10.8M	$11.9M	$4.4M
Research and Development Expense	$899.6M	—	—	—	$461.5M
Selling, General and Administrative Expense	$232.6M	$150.3M	$186.3M	$354.3M	$286.6M
Operating Expenses	—	—	—	—	—
Operating Income (Loss)	-$353.7M	-$410.2M	-$30.2M	-$172.1M	$365.9M
Interest Expense	$12.7M	$8.1M	$9.3M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$3.0B	$3.0B	$2.5B	$2.6B	$2.4B
Assets, Current	$2.6B	$2.6B	$2.2B	$2.3B	$2.1B
Cash and Cash Equivalents, at Carrying Value	$242.1M	$399.3M	$276.5M	$869.2M	$397.7M
Inventory, Net	$12.5M	$7.4M	$22.0M	$24.8M	$22.0M
Liabilities	$2.4B	$2.6B	$2.0B	$1.8B	$1.6B
Liabilities, Current	$309.3M	$448.1M	$311.6M	$240.6M	$598.9M
Long-term Debt	$1.8B	$1.3B	$1.3B	$1.2B	—

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$307.5M	-$274.4M	$30.8M	$35.9M	$345.6M
Net Cash Provided by (Used in) Investing Activities	-$214.1M	-$262.6M	$194.9M	$274.5M	-$41.3M
Net Cash Provided by (Used in) Financing Activities	$644.1M	-$55.3M	$245.9M	-$596.6M	$100.0M
Payments to Acquire Property, Plant, and Equipment	$23.8M	$15.7M	$12.0M	$35.1M	$30.9M
Payments for Repurchase of Common Stock	—	—	—	$34.4M	$34.4M

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)